Delta sleep-inducing peptide (DSIP): a still unresolved riddle

Delta Sleep-Inducing Peptide (DSIP) has intrigued researchers since its discovery, with biological activities that extend far beyond its name suggests. This comprehensive review by Kovalzon and Strekalova explored the multifaceted neurobiological activities of DSIP, attempting to resolve the many questions surrounding this enigmatic peptide.

The authors reviewed decades of research on DSIP's biological effects, covering its roles in sleep regulation, stress protection, pain modulation, neuroendocrine function, and neuroprotection. The review addressed both well-established findings and areas where the peptide's mechanisms remain incompletely understood.

The review confirmed DSIP's remarkably diverse neurobiological activities spanning stress protection, pain modulation, and sleep regulation. The peptide's ability to influence multiple neurological systems simultaneously suggests it acts as a broad-spectrum neuromodulator rather than a simple sleep-inducing agent.

DSIP's multifaceted neurobiological profile underscores significant untapped therapeutic potential. For the peptide therapy field, DSIP represents an opportunity to address multiple neurological concerns with a single agent, particularly for patients dealing with the interconnected challenges of sleep disruption, stress, and pain.